Irina A. Anselm

Irina A. Anselm, MD is Assistant Professor of Neurology at Harvard Medical School and Director of the Mitochondrial Program at Boston Children's Hospital. She co-directs the Neurometabolic Program and serves as clinical expert for the hospital's Precision Medicine Service. Her work spans pediatric neurology, neurogenetics, and mitochondrial medicine.

• Medical School: St. Petersburg Pediatric Medical Academy (1984)
• Residency: University of Massachusetts Medical Center (1995)
• Fellowship: New England Medical Center (1998)

Dr. Anselm specializes in mitochondrial disorders and neurometabolic syndromes affecting children. Her research focuses on genetic diagnosis, experimental therapies, and clinical management of these complex conditions. She leads clinical trials evaluating novel treatments like dichloroacetate (DCA) for lactic acidemia and collaborates with biotech companies on gene therapy approaches.

Key publication areas include mitochondrial disease pathophysiology, neurodevelopmental genetic mutations, and experimental treatment outcomes. She has authored consensus guidelines for mitochondrial disease management and serves as reviewer for multiple journals including Journal of Pediatric Neurology and Current Pediatric Reviews.